Stock Price Forecast

May 3, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading FATE THERAPEUTICS INC chart...

About the Company

We do not have any company description for FATE THERAPEUTICS INC at the moment.

Exchange

Nasdaq

$236M

Total Revenue

482

Employees

$401M

Market Capitalization

-2.49

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $FATE News

Forecasting The Future: 8 Analyst Projections For Fate Therapeutics

10h ago, source:

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $7.25, a high ...

Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2024 Financial Results and Operational Updates

18h ago, source: Yahoo Finance

SAN DIEGO, May 06, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a ...

Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting

3d ago, source:

Off-the-shelf, CD19-targeted CAR NK Cell Product Candidate Drives Rapid and Deep Depletion of SLE Donor CD19+ B cells ADR ...

Fate Therapeutics: Looking For A Potential Turnaround In 2024

7d ago, source:

Fate Therapeutics has faced setbacks, including the termination of a partnership with Janssen Pharmaceuticals. Read more ...

What Direction Does Fate Therapeutics Inc (NASDAQ: FATE) Analysts Think The Company Will Take?

13d ago, source:

Fate Therapeutics Inc, whose market valuation is $544.06 million at the time of this writing. Investors’ optimism about the ...

Fate Therapeutics Inc FATE

8d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Fate Therapeutics: As Its Rally Fizzles, We May Be Near The Bottom

7d ago, source:

Fate Therapeutics, Inc. shows promise in the cell therapy market with the successful CAR T-cell project, but high cash burn rate may pose a risk. Learn more on FATE stock here.

How to get Fate Fabric in Hades 2

9h ago, source:

Fate Fabric is by speaking with the Wretched Broker at your camp Hades 2 Hades Hades 2 Hades 2 Hades 2 ...

Faye Dunaway, Harvey Keitel & Andrew McCarthy To Star In Jonathan Baker’s ‘Fate’

on MSN ago, source:

Faye Dunaway, Harvey Keitel and Andrew McCarthy are set to star in 'Fate,' a new film from director Jonathan Baker.

Our Reporter on the Fate of a Gazan University Class

13d ago, source:

These university graduates in Gaza finished training just one week before the war began. We reached out to everyone in the ...

Lords of the Fallen version 1.5 update ‘Master of Fate’ now available

12d ago, source: gematsu

Publisher CI Games and developer Hexworks have released the Lords of the Fallen version 1.5 update “Master of Fate,” which ...

Lords of the Fallen - Official Version 1.5: Master of Fate Trailer

on MSN ago, source:

Join Saul Gascon, Head of Studio at HEXWORKS, for an update on Lords of the Fallen, and get a deep dive into the Version 1.5: ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...